(Q36607337)

15 August 2017

1 reference

title

Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies (English)

1 reference

15 August 2017

0 references

Emanuela Tumini

2

0 references

Elisa Porcellini

object named as

Elisa Porcellini

series ordinal

3

0 references

author name string

Martina Chiappelli

series ordinal

1

1 reference

PubMed ID

17009920

15 August 2017

Federico Licastro

series ordinal

4

1 reference

15 August 2017

1 September 2006

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

9

1 reference

15 August 2017

1327-1336

1 reference

Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease

15 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

The participation of interleukin-6 in the pathogenesis of alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Amyloid beta protein precursor and the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Microglia in degenerative neurological disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Regional differences in reactive gliosis induced by substrate-bound beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Glial cytokines in Alzheimer's disease: review and pathogenic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Activation of the classical complement pathway in brain tissue of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Age-dependent association between interleukin-1A (-889) genetic polymorphism and sporadic Alzheimer's disease. A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Sympathetic neurons can produce and respond to interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Physiological and pathological roles of interleukin-6 in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin-10 (IL-10) genotypes in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Human plasma proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Polymorphism in the alpha(1)-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Protein prenylation: molecular mechanisms and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

High-density lipoprotein cholesterol and the role of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

The role of cholesterol in the biosynthesis of beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Nonlipid-lowering effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Statins as potential therapeutic agents in neuroinflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Inflammatory processes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Cytokines: Principles and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.9.1327

10.1586/14737175.6.9.1327

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17009920